Viewing Study NCT01620060


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-28 @ 12:14 AM
Study NCT ID: NCT01620060
Status: COMPLETED
Last Update Posted: 2016-04-08
First Post: 2012-05-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lurasidone Pediatric Pharmacokinetics Study
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D1050300
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators